Takeda, Abingworth provide a $100M bankroll for an upstart T cell player, building in a buyout option
Over the past year Takeda has been ripping up its old global R&D organization and creating a new one, with a whole new set …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
